Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 15Hyperandrogenism 6Endometrial Neoplasms 3Breast Neoplasms 3Osteoporosis 2Endometrial Hyperplasia 2Uterine Cervical Dysplasia 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Progesterone Resistance 1Obesity 1Menorrhagia 1Leiomyoma 1Infertility, Female 1Infertility 1Hot Flashes 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Cardiovascular Diseases 1Brain Neoplasms 1Anovulation 1Abortion, Spontaneous 1

Interventions

Metformin 10Clomiphene 10Inositol 3Medroxyprogesterone Acetate 2Letrozole 2Glycoprotein Hormones, alpha Subunit 2Folic Acid 2Chorionic Gonadotropin 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Lactalbumin 1Inulin 1Flutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anovulation × Progesterone × Clear all
NCT03088046 2017-03-23

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Fundacion Dexeus

Phase NA Completed
15 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡